Meeder Asset Management’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | – | Sell |
-567
| Closed | -$2K | – | 1966 |
|
2018
Q4 | $2K | Buy |
567
+230
| +68% | +$811 | ﹤0.01% | 1610 |
|
2018
Q3 | $3K | Buy |
337
+59
| +21% | +$525 | ﹤0.01% | 1424 |
|
2018
Q2 | $2.01K | Buy |
278
+116
| +72% | +$840 | ﹤0.01% | 1415 |
|
2018
Q1 | $1K | Sell |
162
-193
| -54% | -$1.19K | ﹤0.01% | 1524 |
|
2017
Q4 | $3K | Sell |
355
-350
| -50% | -$2.96K | ﹤0.01% | 1465 |
|
2017
Q3 | $6K | Buy |
705
+221
| +46% | +$1.88K | ﹤0.01% | 1242 |
|
2017
Q2 | $6K | Hold |
484
| – | – | ﹤0.01% | 1172 |
|
2017
Q1 | $5K | Sell |
484
-1,513
| -76% | -$15.6K | ﹤0.01% | 1125 |
|
2016
Q4 | $19K | Buy |
+1,997
| New | +$19K | ﹤0.01% | 669 |
|
2015
Q4 | – | Sell |
-7
| Closed | – | – | 878 |
|
2015
Q3 | $0 | Buy |
+7
| New | – | ﹤0.01% | 736 |
|